{"id":207666,"name":"SIGA TECHNOLOGIES, INC.","slug":"siga-technologies-inc","state":"NY","country":"United States of America","description":"biodefense countermeasure pharmaceutical company","totalSpending":1520000,"filings":22,"yearlySpending":[{"year":2020,"income":50000},{"year":2021,"income":240000},{"year":2022,"income":240000},{"year":2023,"income":240000},{"year":2024,"income":240000},{"year":2025,"income":510000}],"issues":["BUD","DEF","HCR"],"firms":["TIDES GROUP, LLC"],"lobbyists":["EVAN KNISELY"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Executive Office of the President (EOP)","Defense, Dept of (DOD)","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Issues related to biodefense countermeasures","Issues related to biodefense countermeasures","Issues related to biodefense countermeasures","H.R. 133, Consolidated Appropriations Act FY2021- Issues related to biodefense countermeasures.","H.R. 133, Consolidated Appropriations Act FY2021- Issues related to biodefense countermeasures."],"years":[2020,2021,2022,2023,2024,2025]}